Correction: Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU. . Gut 2025;74:e16.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction: Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU. Gut 2025;74:e16.
PMID: 40623728